Skip to main content
Equibles
ALLO logo

ALLO · Allogene Therapeutics, Inc.

Track ALLO — free

Use ALLO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ALLO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.05 +0.07 (+3.54%) At close · Aug 14
Market Cap
$708.26M
Shares
345.49M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
60,209,180 -0.9% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
89/100
Short interest 17.6% of shares — P97 Days to cover 9.2 — P87 Price vs VWAP +2.3% — P58 Short-volume trend +2.2% — P60 Short interest change +1.7% — P63 Worst FTD 0.27% of shares — P87 Earnings soon +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 60,753,788 59,712,398 +1,041,390 9.23
    2026-07-15 59,712,398 63,385,047 -3,672,649 6.35
    2026-06-30 63,385,047 48,035,062 +15,349,985 5.14
    2026-06-15 48,035,062 44,480,150 +3,554,912 6.21
    2026-05-29 44,480,150 42,275,161 +2,204,989 6.77
    2026-05-15 42,275,161 36,856,587 +5,418,574 6.41
    2026-04-30 36,856,587 36,379,520 +477,067 3.71
    2026-04-15 36,379,520 32,060,091 +4,319,429 1.60
    2026-03-31 32,060,091 24,421,757 +7,638,334 4.81
    2026-03-13 24,421,757 23,927,216 +494,541 6.21
    2026-02-27 23,927,216 19,964,416 +3,962,800 3.96
    2026-02-13 19,964,416 18,819,473 +1,144,943 3.74
    2026-01-30 18,819,473 18,633,438 +186,035 2.59
    2026-01-15 18,633,438 18,077,704 +555,734 3.51
    2025-12-31 18,077,704 18,038,394 +39,310 6.36
    2025-12-15 18,038,394 18,663,734 -625,340 7.53
    2025-11-28 18,663,734 18,695,485 -31,751 7.62
    2025-11-14 18,695,485 19,094,028 -398,543 8.02
    2025-10-31 19,094,028 19,491,965 -397,937 7.68
    2025-10-15 19,491,965 19,201,999 +289,966 6.08
    2025-09-30 19,201,999 20,285,441 -1,083,442 5.43
    2025-09-15 20,285,441 19,943,094 +342,347 9.49
    2025-08-29 19,943,094 24,472,217 -4,529,123 5.25
    Showing 1–23 of 23 settlements
    Key facts CIK 1737287 CUSIP 019770106 13F (30d) 203 filings 200 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)